domingo, 2 de febrero de 2025

CDK4/6 Inhibitors in the Treatment of HR+ Breast Cancer Nancy Nixon, MD · University of Calgary · Arthur Child Cancer Centre

https://decisionpoint.medscape.com/oncology/viewarticle/1001844

No hay comentarios:

Publicar un comentario